Related Experiment Video
Updated: Jun 25, 2026
05:01
Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury
Published on: August 16, 2019
Emerging treatments for traumatic brain injury
Ye Xiong1, Asim Mahmood, Michael Chopp
1Henry Ford Health System, Department of Neurosurgery, Detroit, MI 48202, USA.
Expert Opinion on Emerging Drugs
|March 3, 2009
Summary
New treatments for traumatic brain injury (TBI) show promise. Therapies like stem cells, erythropoietin, and exercise may improve outcomes, with more clinical trials planned.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Clinical Trials
Background:
- Traumatic brain injury (TBI) presents complex challenges in neurological deficit management.
- Understanding TBI pathophysiology is crucial for developing effective treatments.
Purpose of the Study:
- To review emerging therapeutic strategies for TBI in preclinical and clinical stages.
- To describe the pathophysiology of neurological deficits following TBI.
- To present therapies with potential neuroprotective and neurorestorative effects.
Main Methods:
- Comprehensive literature review of preclinical TBI studies.
- Analysis of clinical TBI trials focusing on neuroprotection and neurorestoration.
Main Results:
- Most neuroprotection clinical trials (Phase II/III) have not yielded consistent positive outcomes for TBI patients.
- Emerging therapies show potential for reducing brain injury and promoting brain remodeling.
Conclusions:
- Future clinical trials will focus on translating preclinical findings for TBI treatment.
- Promising approaches include erythropoietin, statins, stem cells, and enriched environments.
- These therapies aim to improve functional outcomes through neuroprotection, angiogenesis, neurogenesis, and synaptogenesis.
